Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The Phase 3 STRIDE trial enrolled almost 800 adults with Type 2 diabetes and PAD and found that semaglutide 1 mg once weekly improved maximum walking distance by almost 13% Over placebo at 52 weeks
Disclaimers Research-use disclaimer: The products and compounds discussed are sold for laboratory and research use only
These medications work by mimicking the glucagon-like peptide-1 (GLP-1) hormone, which helps control blood sugar levels and promotes weight loss
Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
US$ 22.63
US$ 26.04
US$ 24.90
US$ 20.77
US$ 20.78
